The estimated Net Worth of Amy B. Summy is at least $1.74 million dollars as of 1 April 2024. Ms. Summy owns over 3,500 units of Labcorp stock worth over $867,703 and over the last 5 years she sold LH stock worth over $875,393. In addition, she makes $0 as Executive Vice President et Chief Marketing Officer at Labcorp.
Sign up
Ms. Summy LH stock SEC Form 4 insiders trading
Amy has made over 14 trades of the Labcorp stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 3,500 units of LH stock worth $760,515 on 1 April 2024.
The largest trade she's ever made was exercising 5,778 units of Labcorp stock on 27 March 2024 worth over $1,261,280. On average, Amy trades about 659 units every 58 days since 2020. As of 1 April 2024 she still owns at least 3,975 units of Labcorp stock.
You can see the complete history of Ms. Summy stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Amy Summy biography
Amy B. Summy serves as Executive Vice President, Chief Marketing Officer of the Company. Amy B. Summy has served as Executive Vice President and Chief Marketing Officer since March 2, 2020. Prior to joining LabCorp, she was Partner, Marketing & Insights Practice Leader for the Americas for Ernst & Young from February 2018 to February 2020. From January 2013 to January 2018, Ms. Summy was Senior Vice President and Chief Marketing Officer for TE Connectivity Ltd., where she built the marketing organization, establishing a digitally centered, customer-driven marketing capability for the company. Prior to that, Ms. Summy was Senior Vice President from July 2011 to December 2012. Ms. Summy also worked for Sapient and SapientNitro from 1996 to 2011, where she held executive agency leadership roles including Managing Director and Chief Marketing Officer. Ms. Summy received her Bachelor’s degree in Finance from Kent State University and holds a Master’s degree in Business Administration from New York University’s Stern School of Business. Ms. Summy co-founded and is a Board Member for No More Kids with Cancer, a childhood cancer research nonprofit dedicated to accelerating the discovery of safer, less toxic and more effective treatments for children with cancer.
How old is Amy Summy?
Amy Summy is 54, she's been the Executive Vice President et Chief Marketing Officer of Labcorp since 2020. There are 19 older and 6 younger executives at Labcorp. The oldest executive at Labcorp Holdings Inc. is Jean-Luc Belingard, 71, who is the Independent Director.
What's Amy Summy's mailing address?
Amy's mailing address filed with the SEC is 531, South Spring Street, Burlington, Alamance County, North Carolina, 27215, United States.
Insiders trading at Labcorp
Over the last 19 years, insiders at Labcorp have traded over $236,972,149 worth of Labcorp stock and bought 10,666 units worth $1,520,331 . The most active insiders traders include Mahon Thomas P Mac, Garheng Kong et David P King. On average, Labcorp executives and independent directors trade stock every 11 days with the average trade being worth of $2,652,442. The most recent stock trade was executed by Der Vaart Sandra D Van on 19 August 2024, trading 2,000 units of LH stock currently worth $454,100.
What does Labcorp do?
recognized for our innovation, quality, and customer convenience, labcorp delivers timely, accurate results for improved patient care. with scientific expertise in esoteric testing, genomics, and clinical and anatomic pathology, labcorp performs more than one million tests on approximately 400,000 samples each day. labcorp is a pioneer in applying advances in medicine and science to laboratory testing, with more than 35 years of experience in serving physicians and their patients. labcorp operates a sophisticated laboratory network, with corporate headquarters in burlington, nc, and more than 34,000 employees worldwide. our more than 220,000 clients include physician offices, hospitals, managed care organizations, and biotechnology and pharmaceutical companies. laboratory corporation of america holdings is listed on the new york stock exchange (nyse) under ticker symbol lh.
What does Labcorp's logo look like?
Complete history of Ms. Summy stock trades at Labcorp
Labcorp executives and stock owners
Labcorp executives and other stock owners filed with the SEC include:
-
Glenn Eisenberg,
Chief Financial Officer, Executive Vice President -
Adam Schechter,
President, Chief Executive Officer, Director -
Adam H. Schechter,
Pres, CEO & Chairman -
Brian Caveney,
Executive Vice President, President, Diagnostics and Chief Medical Officer -
Lance Berberian,
Executive Vice President, Chief Technology Officer, Chief Information Officer -
Mark Schroeder,
Executive Vice President, President of Diagnostics Laboratory Operations and Global Supply Chain -
Glenn A. Eisenberg,
CFO & Exec. VP -
Mark S. Schroeder,
Exec. VP and Pres of Diagnostics Laboratory Operations & Global Supply Chain -
Dr. Paul R. Kirchgraber M.D.,
Exec. VP & CEO of Covance Drug Devel. -
Dr. Brian J. Caveney M.P.H., M.D., J.D., MPH,
Exec. VP, Pres of Diagnostics & Chief Medical Officer -
Peter Neupert,
Lead Independent Director -
Kerrii Anderson,
Independent Director -
Garheng Kong,
Independent Director -
Robert Williams,
Independent Director -
Richelle Parham,
Independent Director -
D. Gary Gilliland,
Independent Director -
Jean-Luc Belingard,
Independent Director -
Jeffrey Davis,
Independent Director -
Clarissa Willett,
Vice President, Investor Relations -
Peter Wilkinson,
Senior Vice President, Chief Accounting Officer -
Paul Kirchgraber,
Executive Vice President and Chief Executive Officer - Covance Drug Development -
Sandra Van Der Vaart,
Executive Vice President, Chief Legal Officer, Chief Compliance Officer and Secretary -
Amy Summy,
Executive Vice President, Chief Marketing Officer -
Judith Seltz,
Chief Human Resource Officer, Executive Vice President -
Chas Cook,
VP of Investor Relations -
Dr. Marcia T. Eisenberg Ph.D.,
Chief Scientific Officer & Sr. VP -
Lance V. Berberian,
Exec. VP and Chief Information & Technology Officer -
Peter J. Wilkinson,
Sr. VP & Chief Accounting Officer -
Dr. Michelle Abelson Ph.D.,
Laboratory Director of Operations -
Anita Z Graham,
EVP, CHRO -
R Sanders Williams,
Director -
Edward T Dodson,
Principal Accounting Officer -
Lisa J Uthgenannt,
Chief Human Resources Officer -
David P King,
Director -
M. Huff Gary,
CEO, LabCorp Diagnostics -
John D Ratliff,
CEO, Covance Drug Development -
F Samuel Iii Eberts,
Chief Legal Officer, Secretary -
Robert E Jr Mittelstaedt,
Director -
Kathryn E Wengel,
Director -
Thomas Pike,
Pres & CEO Clinical Business -
Arthur H Rubenstein,
Director -
M Keith Weikel,
Director -
William B Hayes,
Sr. Vice President -
Wendy E Lane,
Director -
Lidia Fonseca,
Chief Information Officer -
Bradford T Smith,
EVP, Chf Legal Offcr,Secretary -
Don M Hardison,
EVP, COO -
Mahon Thomas P Mac,
CEO and Chairman of the Board -
N Anthony Coles,
Director -
William Haas,
EVP, Sales & Marketing -
Andrew J Conrad,
EVP, Chief Scientific Officer -
Goldman Myla Lai,
EVP & Chief Medical Officer -
Benjamin R Miller,
EVP, Oncology Products & Serv -
Andrew G Wallace,
Director -
Allen W Troub,
EVP, Western Operations -
Woodrow L Cook,
EVP, Eastern Operations -
Richard L Novak,
EVP & Strategic Planning -
Deborah L Keller,
CEO, Covance Drug Development -
James T. Jr. Boyle,
Senior Vice President -
Joseph L Herring,
CEO of Covance Drug Division -
Mark E Brecher,
Chief Medical Officer -
Kirsten Marie Kliphouse,
Director -
Paul Rothman,
Director -
Jonathan P. Di Vincenzo,
EVP, Pres, Central Labs & Intl -
Megan D. Bailey,
EVP, Chief Strategy Officer